Skip to content

Redon drain blood quality before and after cell saver processing during CABG procedures: a pilot study

Redon drain blood quality before and after cell saver processing during CABG procedures: a pilot study - Redon drain cell saver

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49048
Enrollment
100
Registered
2020-02-12
Start date
2020-03-02
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autotransfusion transfusion with own blood

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Scheduled for elective CABG with the use of saphenous vein graft material Age >=18 years Capable of understanding and speaking Dutch.

Exclusion criteria

Exclusion criteria: Hematologic disorders Sepsis Unable to correctly understand the research by means of different langue barrier or mental impairment Less than 50 ml of blood has been collected in the redon drain at the end of the surgery

Design outcomes

Primary

MeasureTime frame
Blood rheology

Secondary

MeasureTime frame
Blood gas parameters Baseline platelet activation and activation triggered by a receptor activator Inflammatory markers: Interleukin -6 (CXCL6), Interleukin -8 (CXCL8) and tumor necrosis factor-a (TNF-a) Hemolysis index

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)